These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 12563705

  • 1. B cell loss leading to remission in severe systemic lupus erythematosus.
    Tarrant TK, Frazer DH, Aya-Ay JP, Patel DD.
    J Rheumatol; 2003 Feb; 30(2):412-4. PubMed ID: 12563705
    [Abstract] [Full Text] [Related]

  • 2. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
    Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.
    Arthritis Rheum; 2009 Apr 15; 61(4):482-7. PubMed ID: 19333973
    [Abstract] [Full Text] [Related]

  • 3. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec 15; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 4. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.
    Ann Rheum Dis; 2008 Jul 15; 67(7):1011-6. PubMed ID: 17962238
    [Abstract] [Full Text] [Related]

  • 5. Common variable immunodeficiency in systemic lupus erythematosus.
    Fernández-Castro M, Mellor-Pita S, Citores MJ, Muñoz P, Tutor-Ureta P, Silva L, Vargas JA, Yebra-Bango M, Andreu JL.
    Semin Arthritis Rheum; 2007 Feb 15; 36(4):238-45. PubMed ID: 17276173
    [Abstract] [Full Text] [Related]

  • 6. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
    Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I.
    Arthritis Rheum; 2004 Nov 15; 50(11):3580-90. PubMed ID: 15529346
    [Abstract] [Full Text] [Related]

  • 7. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan 15; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 8. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 15; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 9. Transient panhypogammaglobulinaemia and B-lymphocyte deficiency in a patient with neuropsychiatric systemic lupus erythematosus after immunosuppressive therapy.
    Song J, Park YB, Suh CH, Lee SK.
    Clin Rheumatol; 2003 Feb 15; 22(1):62-6. PubMed ID: 12605322
    [Abstract] [Full Text] [Related]

  • 10. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG, Jones RB, Burns SM, Jayne DR.
    Arthritis Rheum; 2006 Sep 15; 54(9):2970-82. PubMed ID: 16947528
    [Abstract] [Full Text] [Related]

  • 11. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A, Jacobi AM, Mei H, Hiepe F, Dörner T.
    Lupus; 2008 Dec 15; 17(12):1064-9. PubMed ID: 19029273
    [Abstract] [Full Text] [Related]

  • 12. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
    Albert D, Dunham J, Khan S, Stansberry J, Kolasinski S, Tsai D, Pullman-Mooar S, Barnack F, Striebich C, Looney RJ, Prak ET, Kimberly R, Zhang Y, Eisenberg R.
    Ann Rheum Dis; 2008 Dec 15; 67(12):1724-31. PubMed ID: 18250115
    [Abstract] [Full Text] [Related]

  • 13. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O.
    Scand J Immunol; 2007 Nov 15; 66(5):584-90. PubMed ID: 17868260
    [Abstract] [Full Text] [Related]

  • 14. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.
    Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J, Looney RJ.
    Arthritis Rheum; 2003 Feb 15; 48(2):455-9. PubMed ID: 12571855
    [Abstract] [Full Text] [Related]

  • 15. Repeated B cell depletion in treatment of refractory systemic lupus erythematosus.
    Ng KP, Leandro MJ, Edwards JC, Ehrenstein MR, Cambridge G, Isenberg DA.
    Ann Rheum Dis; 2006 Jul 15; 65(7):942-5. PubMed ID: 16269424
    [Abstract] [Full Text] [Related]

  • 16. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
    Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y.
    Rheumatology (Oxford); 2006 Jul 15; 45(7):851-4. PubMed ID: 16418192
    [Abstract] [Full Text] [Related]

  • 17. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May 15; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 18. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT, Peeva E.
    Semin Arthritis Rheum; 2008 Dec 15; 38(3):218-27. PubMed ID: 18206214
    [Abstract] [Full Text] [Related]

  • 19. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA.
    Br J Dermatol; 2004 Apr 15; 150(4):693-700. PubMed ID: 15099365
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y.
    Rheumatology (Oxford); 2005 Feb 15; 44(2):176-82. PubMed ID: 15494350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.